SCHEMBL24729587

SCHEMBL24729587

CC1(C)c2ccccc2-c2ccccc2-c2ccccc2-c2ccccc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.47
MLNR O43193 1/20 0.47
NR1I2 O75469 1/20 0.47
CHRM2 P08172 1/20 0.47
ADRB1 P08588 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47
CHRM1 P11229 1/20 0.47
DRD2 P14416 1/20 0.47
ADRA2B P18089 1/20 0.47
ADRA2C P18825 1/20 0.47
CHRM3 P20309 1/20 0.47
DRD1 P21728 1/20 0.47
SLC6A2 P23975 1/20 0.47
HTR2C P28335 1/20 0.47
SLC6A4 P31645 1/20 0.47
ADRA1A P35348 1/20 0.47
HRH1 P35367 1/20 0.47
OPRM1 P35372 1/20 0.47
DRD3 P35462 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29363404 0.97 HTR2A (0.48) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL283246 0.97 HTR2A (0.48) HTR2AMLNRNR1I2CHRM2ADRB1
Lithium SCHEMBL30363455 0.94 HTR2A (0.47) HTR2AMLNRNR1I2CHRM2ADRB1
Benzene SCHEMBL28919541 0.94 PGR (0.48) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL28942003 0.94 HTR2A (0.47) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL5014621 0.87 HTR2A (0.43) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL5062909 0.87 HTR2A (0.43) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL21759261 0.85 HTR2A (0.46) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL21368848 0.83 KDM4E (0.46) HTR2AMLNRNR1I2CHRM2ADRB1
SCHEMBL29607648 0.83 KDM4E (0.46) HTR2AMLNRNR1I2CHRM2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220281905-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220281905-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES L1CAM, CHRM1, SSB HTR2A 3860/4885MLNR 2143/4885NR1I2 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.